Related by context. All words. (Click for frequent words.) 81 infarction STEMI 79 segment elevation myocardial 75 infarction NSTEMI 73 acute myocardial infarction AMI 72 unstable angina UA 70 unstable angina 70 STEMI 69 acute coronary syndrome 69 acute coronary syndromes 69 resuscitated cardiac arrest 68 coronary revascularization 67 elevation acute myocardial 67 STEMI ST 67 myocardial infarction 67 reinfarction 67 myocardial infarction MI 66 elevation acute coronary 66 acute myocardial infarction 66 angina pectoris 66 coronary intervention 66 unstable angina pectoris 66 thrombolytic therapy 66 repeat revascularization 66 NSTEMI 66 STEMIs 65 myocardial infarctions 65 stable angina 65 reperfusion therapy 65 sustained ventricular tachycardia 65 fibrinolytic therapy 65 revascularization 64 UA NSTEMI 64 NSTE ACS 64 infarction 64 periprocedural 64 cardiogenic shock 64 fatal myocardial infarction 64 STEMI patients 64 recurrent ischemia 64 thromboembolism 64 elevation myocardial infarction 64 nonfatal myocardial infarction 64 primary percutaneous coronary 63 ST Segment Elevation 63 ischemic complications 63 Venous thromboembolism 63 acute coronary syndromes ACS 63 MACCE 63 Thrombolysis 63 ischemic cardiomyopathy 63 thrombotic events 63 patients undergoing percutaneous 63 TAXUS Express Stent 63 Acute Myocardial Infarction 63 revascularization procedures 63 ventricular tachycardia VT 62 revascularisation 62 antithrombotic therapy 62 myocardial ischemia 62 thromboembolic events 62 silent ischemia 62 atrial fibrillation AF 62 tirofiban 62 Percutaneous Coronary Intervention 62 refractory ischemia 62 undergoing coronary artery 62 non valvular atrial 62 eptifibatide 61 aspirin clopidogrel 61 Acute Coronary Syndrome 61 ipsilateral stroke 61 acute ischemic stroke 61 postoperative AF 61 progressive dyspnea 61 coronary revascularization procedures 61 stroke transient ischemic 61 recurrent glioblastoma multiforme 61 multivessel disease 61 thrombolytic agents 61 carotid endarterectomy 61 left ventricular dysfunction 61 percutaneous coronary intervention 61 NATRECOR R 61 PICSO ® 60 definite stent thrombosis 60 thromboembolic 60 myocardial infarction stroke 60 heparin induced thrombocytopenia 60 percutaneous intervention 60 beta blocker therapy 60 LV dysfunction 60 CYPHER Stent 60 ventricular arrhythmia 60 tenecteplase 60 thrombolysis 60 fibrinolysis 60 cardiovascular hospitalization 60 nonfatal MI 60 severe exacerbations 60 coronary interventions 60 Ventricular Tachycardia 60 coronary angiography 60 Infarction 60 cerebrovascular accident 60 Erythropoietic therapies may 60 ventricular tachyarrhythmias 60 Stent thrombosis 60 recurrent VTE 60 urgent coronary revascularization 60 Taxus Stent 60 infarctions 60 CYPHER ® Stent 60 drug eluting stent implantation 60 cerebrovascular events 60 systemic embolism 60 TEAEs 59 ximelagatran 59 percutaneous transluminal coronary angioplasty 59 percutaneous coronary interventions 59 occlusive disease 59 decompensated heart failure 59 patients undergoing CABG 59 angioplasty stenting 59 post thrombotic syndrome 59 ischemic stroke 59 TIA transient ischemic 59 upper gastrointestinal bleeding 59 ischemic 59 valvular disease 59 ST Elevation Myocardial 59 unstable angina chest 59 lobectomy 59 events MACE 59 composite endpoint 59 ischemia driven 59 stent placement 59 nonfatal myocardial infarction MI 59 cerebrovascular accidents 59 stable angina pectoris 59 antiplatelet agents 59 ventricular fibrillation VF 59 onset atrial fibrillation 59 bypass grafting 59 ventricular tachyarrhythmia 59 paclitaxel eluting stents 59 arterial revascularization 59 pericardial effusion 59 cardiac resynchronisation therapy 59 nonischemic 59 ICD implantation 59 tissue plasminogen activator tPA 59 atherothrombotic disease 59 coronary revascularisation 59 bypass graft CABG surgery 59 clopidogrel Plavix 58 stent implantation 58 proliferative diabetic retinopathy 58 aldosterone antagonist 58 thrombolytics 58 carotid artery blockage 58 Myocardial Infarction 58 carotid endarterectomy CEA 58 sirolimus eluting stents 58 DVT PE 58 clopidogrel 58 XIENCE V demonstrated 58 LVSD 58 oral anticoagulation 58 thrombus aspiration 58 Acute Coronary Syndromes 58 rosuvastatin #mg 58 transurethral resection 58 revascularization procedure 58 thrombocytopenic 58 XIENCE V PROMUS Stent 58 CABG surgery 58 antiplatelet therapy 58 carotid stenosis 58 dual antiplatelet therapy 58 renal insufficiency 58 coronary artery disease 58 cardiovascular hospitalizations 58 tumor lysis syndrome 58 Acute myocardial infarction 58 acute coronary 58 paroxysmal AF 58 recurrent DVT 58 stenting 58 perioperative mortality 58 thromboprophylaxis 58 ARIXTRA 58 Ventricular tachycardia 58 endarterectomy 58 antiarrhythmic drug 58 carotid artery stenting CAS 58 arteriography 58 acute decompensation 58 hemodynamic instability 58 transient ischemic attack 58 NATRECOR ® 58 surgical revascularization 58 intracoronary 58 severe hypoglycemic 58 cardiac dysfunction 58 levodopa therapy 58 target lesion revascularization 58 symptomatic VTE 58 cardiopulmonary bypass CPB 58 DAPT 58 nonfatal stroke 58 VT VF 58 Unstable Angina 57 renal dysfunction 57 ventricular tachycardia 57 intracerebral hemorrhage 57 ticagrelor 57 resynchronization therapy 57 acute myocardial 57 postoperative atrial fibrillation 57 Coronary Artery Bypass Graft 57 VTE 57 eplerenone 57 recombinant tissue plasminogen 57 sirolimus stent 57 undergoing CABG 57 Ischemic stroke 57 mm Stent 57 aortic stenosis 57 unfractionated heparin 57 thrombotic complications 57 ICD shocks 57 IIIa inhibitor 57 glycoprotein IIb IIIa inhibitors 57 NMIBC 57 antiplatelet drugs 57 pulmonary embolism PE 57 PLX STROKE targeting 57 asystole 57 cerebral vasospasm 57 anticoagulation therapy 57 Events MACE 57 functional mitral regurgitation 57 hepatic metastases 57 β blockers 57 clot dissolving drug 57 MIs 57 anticoagulant therapy 57 warfarin therapy 57 myocardial infarction ventricular fibrillation 57 metastatic renal cell carcinoma 57 esophagogastric 57 noncardiac surgery 57 OPCAB 57 aortic valve stenosis 57 acute gout 57 CYPHER R Sirolimus eluting 57 ACUITY trial 57 systolic hypertension 57 Ranolazine 57 Catheter ablation 57 clot busting therapy 57 atrioventricular block 57 Abciximab 57 undergoing angioplasty 57 cerebral vascular 57 bivalirudin 57 target vessel revascularization 57 coronary lesions 57 death dissection perforation 57 AFib 57 ADHF 57 venous thromboembolic disease 57 VTE prophylaxis 57 preserved ejection fraction 57 Coronary artery bypass grafting 57 syncopal 57 lacunar 57 myocardial reperfusion 57 asthma exacerbation 57 rehospitalization 57 thromboembolic complications 57 perioperative complications 57 VIIBRYD 57 risk stratification 57 carotid artery stenting 56 MULTAQ 56 fondaparinux 56 intracerebral hemorrhage ICH 56 preoperative chemotherapy 56 stenoses 56 cryptogenic stroke 56 rhythm disturbances 56 stent thrombosis 56 salmeterol HFA MDI 56 recanalization 56 hypoxemia 56 hepatorenal syndrome 56 revascularizations 56 intracranial bleeding 56 rFVIIa 56 ATACAND 56 abciximab 56 lipid lowering therapy 56 binary restenosis 56 tachyarrhythmias 56 TAXUS stent 56 carotid revascularization 56 vWD 56 XIENCE V vs. 56 extracranial 56 Ischemic 56 renal impairment 56 morphometric vertebral fractures 56 deep vein thromboses 56 NYHA Class II 56 antiplatelet medications 56 Guideline Update 56 infective endocarditis 56 IV NSCLC 56 atherothrombosis 56 claudication 56 GP IIb IIIa inhibitors 56 Myocardial infarction 56 liver resection 56 Atrial flutter 56 BENICAR HCT 56 oral anticoagulation therapy 56 undergoing percutaneous coronary 56 Endarterectomy 56 tachyarrhythmia 56 nonobstructive CAD 56 Acute Coronary Syndromes ACS 56 nicardipine 56 ischemic strokes 56 comorbid conditions 56 nonoperative 56 vertebral fracture 56 bi ventricular pacing 56 coinfected patients 56 bacterial prostatitis 56 symptomatic intracranial 56 paroxysmal atrial fibrillation 56 hepatectomy 56 Stenting 56 systemic corticosteroids 56 infarcts 56 hyperkalemia 56 hemorrhagic strokes 56 CNS systemic embolism 56 undergoing coronary angiography 56 Lactic acidosis 56 Atacand ® 56 invasive aspergillosis 56 VELCADE melphalan 56 aldosterone antagonists 56 torsades de pointes 56 INTEGRILIN R 56 bivalirudin alone 56 LVEF 56 acute myocardial infarctions 56 renal artery stenosis 56 left ventricular hypertrophy 56 FOLFOX4 56 Myocardial Infarction MI 56 subtrochanteric 56 Acute Myocardial Infarction AMI 56 irbesartan 56 postoperative complication 56 colectomy 56 intracranial stenosis 56 necrotizing pancreatitis 56 deep venous thromboses 56 invasive coronary angiography 56 ACTEMRA TM 56 icatibant 56 Postoperative 56 ischemia 56 stent restenosis 56 intravenous diuretics 56 radical nephrectomy 56 cardioembolic stroke 56 acute myocardial infarction MI 56 bradycardia 56 Neovascular AMD 56 aspirin heparin 56 peripheral arterial occlusive disease 56 arterial thromboembolic events 56 left ventricular systolic 56 oral corticosteroid 56 colorectal adenoma 56 rebleeding 56 CABG coronary artery 56 cardiac 56 proximal DVT 56 CABG 56 arrhythmias 55 AGILECT R 55 extrapyramidal symptoms 55 Takotsubo cardiomyopathy 55 transient ischemic attacks 55 everolimus eluting stents 55 antiarrhythmic drugs 55 cytoreductive surgery 55 macrovascular disease 55 prospective multicenter study 55 cerebral perfusion 55 thyrotoxicosis 55 hypotension 55 sidebranch 55 DMARD therapy 55 acute aortic dissection 55 Hemorrhagic stroke 55 hemorrhagic complications 55 β blocker 55 artery stenosis 55 postsurgical 55 angina myocardial infarction 55 aneurysmal subarachnoid hemorrhage 55 acute STEMI 55 lipid lowering drugs 55 cerebral infarction 55 cardiac resynchronization therapy 55 candesartan 55 thromboembolic disease 55 electrical cardioversion 55 FOLFIRI 55 vertebral fractures 55 placebo dexamethasone 55 pacemaker implantation 55 contrast echocardiography 55 NYHA class 55 liver transplant recipients 55 endophthalmitis 55 Acute Ischemic Stroke 55 severe neutropenia 55 TAXUS Express Atom Stent 55 MADRS score 55 TAXUS p value 55 nonrandomized 55 subarachnoid hemorrhage SAH 55 venous thromboembolism VTE 55 atrial fibrillation 55 virologic failure 55 tachycardias 55 syncope 55 antithrombotics 55 microalbuminuria 55 relapsing remitting 55 T2DM 55 alteplase 55 recurrent myocardial infarction 55 torsade de pointes 55 atrophic gastritis 55 sinus bradycardia 55 Myocardial Infarction Study 55 recurrent stroke 55 chronic thromboembolic pulmonary 55 bosentan 55 pelvic lymphadenectomy 55 dronedarone 55 coronary artery bypass grafting 55 PSVT 55 sirolimus eluting stent 55 peri procedural 55 abnormal uterine bleeding 55 vasospasm 55 defibrillator CRT D 55 Percutaneous Transluminal Coronary Angioplasty 55 adrenalectomy 55 zotarolimus eluting stent 55 DEFINITY ® 55 Subarachnoid hemorrhage 55 RAPAFLO R 55 colorectal liver metastases 55 prostate cancer CaP 55 underwent CABG 55 subclinical hypothyroidism 55 severe aortic stenosis 55 carotid stenting 55 invasive candidiasis 55 symptomatic aortic stenosis 55 corticosteroid therapy 55 Endothelial dysfunction 55 EXJADE 55 cTnT 55 mildly symptomatic 55 perioperatively 55 cilostazol 55 renal tumors 55 Acute coronary syndromes 55 mcg QD 55 incisional 55 reoperations 55 pulmonary artery banding 55 death reinfarction 55 mycophenolate mofetil 55 systolic dysfunction 55 radical prostatectomy RP 55 complement inhibitor eculizumab 55 nonoperative treatment 55 postprocedure 55 Genous stent 55 ACC AHA 55 coronary stenting 55 #mg BID [001] 55 intracerebral haemorrhage 55 NYHA 55 APTIVUS r 55 thromboses 55 Nesiritide 55 nondiabetic patients 55 diastolic heart 55 angiographic outcomes 55 anterior uveitis 55 severe renal impairment 55 ticlopidine 55 embolic stroke 55 detrusor overactivity 55 hypoperfusion 55 acetabular fractures 55 Acute Decompensated Heart Failure 55 uncoated stent 55 unfavorable cytogenetics 55 prolonged QT interval 55 aneurysms AAA 55 CABG surgeries 55 Response Evaluation Criteria 55 receiving VELCADE 55 gefitinib Iressa 55 reintervention 55 thiazide diuretic 55 gastric varices 55 valsartan 55 supratentorial 55 Carotid Revascularization Endarterectomy vs. 55 Cypher Stent 55 GP IIb IIIa inhibitor 55 rt PA 55 ventricular arrhythmias 55 distal embolization thrombus formation 54 palliation 54 stage IIIB 54 AA Amyloidosis 54 PSADT 54 beta blockers 54 stratifying patients 54 Doxil ® 54 hemodialysis patients 54 echocardiographic 54 SYNTAX 54 computed tomography angiography 54 Eisenmenger syndrome 54 mycosis fungoides 54 Critical Limb Ischemia CLI 54 inhospital 54 interstitial pneumonia 54 IV tPA 54 fibrinolytic 54 angina 54 enoxaparin 54 prospective multicenter 54 mixed hyperlipidemia 54 mild renal insufficiency 54 intracranial hemorrhage ICH 54 VAPRISOL 54 intracranial hypertension 54 pericardial effusions 54 adrenal insufficiency 54 mitral regurgitation 54 recurrent ischemic 54 atherothrombotic 54 unfractionated heparin UFH 54 degenerative spondylolisthesis 54 angiotensin converting enzyme inhibitors 54 arrythmias 54 uncontrolled bleeding 54 alpha blocker 54 MI STEMI 54 ruptured aneurysms 54 biochemical recurrence 54 reperfusion 54 beta blocker 54 DES implantation 54 neurologic complications 54 angiographically 54 nonvertebral fracture 54 statin therapy 54 coronary blockages 54 elective PCI 54 COPD exacerbation 54 stented 54 COREG 54 TIMI 54 thrombotic 54 Cardiac resynchronization therapy 54 bronchial thermoplasty 54 infarct 54 prostate TURP 54 hypercalcemia 54 Transient Ischemic Attack 54 neoadjuvant therapy 54 irregular quivering 54 tension pneumothorax 54 Unstable angina 54 lopinavir r arm 54 inotropic agents 54 antithrombotic therapies 54 defibrillator implantation 54 hypersensitivity reaction 54 cardioembolic 54 transarterial 54 kidney transplant recipients 54 thrombolytic agent 54 atherosclerotic disease 54 rhythm abnormalities 54 IPAH 54 MDCT angiography 54 coronary insufficiency 54 angiographic restenosis 54 anticoagulant warfarin 54 intra arterial 54 ventricular dysfunction 54 IV bolus 54 Percutaneous coronary intervention 54 intracerebral hemorrhages 54 autonomic dysfunction 54 sternal wound infection 54 Chronic Heart Failure 54 papilledema 54 pyelonephritis 54 cardiogenic pulmonary edema 54 Natalizumab 54 transcatheter aortic valve implantation 54 CK MB 54 ECG abnormalities 54 IIIa inhibitors 54 cinacalcet 54 hemodynamically unstable 54 tolvaptan 54 ß blockers 54 fragility fracture 54 recurrent atrial fibrillation 54 contrast induced nephropathy 54 gastroduodenal 54 coronary vessels 54 intracranial atherosclerosis 54 prednisone prednisolone 54 potent CYP#A# inhibitors 54 NYHA Class III 54 Acute MI 54 aneurysm rupture 54 zotarolimus 54 superficial femoral 54 pheochromocytoma 54 underwent coronary angiography 54 ARCOXIA 54 malperfusion 54 catheter occlusion 54 failure ADHF 54 Hypotension 54 angioedema 54 CsA 54 vascular occlusive diseases 54 PAOD 54 Mitral valve repair 54 diabetic gastroparesis 54 HBeAg negative 54 cerebrovascular 54 Hazard Ratio 54 wedge resection 54 stent thromboses 54 landmark ATHENA trial 54 interferon beta therapy 54 lactic acidosis 54 hyperacute 54 Torsades de Pointes 54 VerifyNow P#Y# Test 54 neurologic symptoms 54 endotracheal intubation 54 stent DES 54 terlipressin 54 atherothrombotic events 54 Carotid stenting 54 macrovascular 54 candidemia 54 paraganglioma 54 generalized seizures 54 esophagectomy 54 Renal impairment 54 TAXUS Liberte Stent 54 antiplatelet medication 54 Fractional Flow Reserve 54 prostate cancer PCa 54 DMARD 54 serum phosphorous 54 chemoradiation therapy 54 uncontrolled hypertension 54 venous thromboembolism 54 hypokalemia hypomagnesemia 54 cerebral angiography 54 otamixaban 54 dosage regimens 54 nonmetastatic prostate cancer 54 gastrointestinal GI motility disorders 54 tamsulosin 54 dyslipidaemia 54 Stent Thrombosis 54 BENICAR 54 refractory angina 54 treat brain aneurysms 54 cytopenias 54 carotid artery disease 54 lung resection 54 anticoagulation 54 ribavirin therapy 54 gout flares 54 elevated serum creatinine 54 Cardiopulmonary bypass 54 primidone 54 cryptogenic 54 % CI #.#-#.# [006] 54 BYSTOLIC 54 TAVR 54 risperidone Risperdal 54 microvascular disease 54 peripheral arterial disease 54 postoperative morbidity 54 intraventricular hemorrhage 54 levosimendan 53 VTEs 53 bifurcation lesions 53 SYNTAX trial 53 neoadjuvant 53 cerebral infarctions 53 relapsing remitting multiple sclerosis 53 metastatic malignant 53 arterial thrombosis 53 Endologix Powerlink System 53 failure NYHA 53 virologic breakthrough 53 squamous histology 53 postoperative pulmonary 53 TAXUS Stent 53 generalized tonic clonic seizures 53 intravenous bisphosphonates 53 diabetes mellitus DM 53 asymptomatic carotid stenosis 53 narrowings 53 inotropic 53 adenomatous 53 TMP SMX 53 serologically active systemic lupus 53 Adjuvant chemotherapy 53 Lenalidomide 53 preserved LVEF 53 cerebral ischemia 53 conventional angiography 53 chemoradiation 53 thrombi 53 Atrial 53 affective psychoses 53 KRAS mutations occur 53 postoperative mortality 53 venous blood clots 53 infarct size 53 Pelvic Organ Prolapse 53 transcranial Doppler ultrasound 53 coronary artery bypass grafts 53 CTEPH 53 SJIA 53 CYPHER R Stent 53 axillary lymph node dissection 53 carotid intima media 53 ALND 53 nesiritide 53 advanced adenomas 53 Thal Dex 53 severe hypoglycemia 53 chlorambucil 53 transplantation HCT 53 endoscopic retrograde 53 hyperglycaemia 53 Score TOS 53 GORE VIABAHN Endoprosthesis 53 concomitant medications 53 overt nephropathy 53 histologically confirmed 53 FluCAM arm 53 androgen deprivation 53 mitoxantrone 53 duplex ultrasonography 53 hematologic toxicity 53 everolimus eluting stent 53 plus GP IIb 53 aneurysm ruptures 53 TAXUS 53 TNF antagonist 53 pyrexia mucositis sepsis febrile 53 Idiopathic pulmonary fibrosis 53 Major Adverse Cardiac 53 aspirin beta blockers 53 calcified plaques 53 CANCIDAS 53 bowel resection 53 laboratory abnormalities 53 nephron sparing surgery 53 akinesia 53 xanthine oxidase inhibitor 53 coronary artery revascularization 53 hypoglycemic events 53 VAD implantation 53 MS DRGs 53 thienopyridine 53 clot busters 53 thrombosis 53 descending thoracic 53 Ejection Fraction 53 recurrent GBM 53 sinus rhythm 53 Amiodarone 53 chemoradiotherapy 53 angiotensin converting enzyme inhibitor 53 Atacand 53 endoleaks 53 DVT prophylaxis 53 PRADAXA #mg 53 VADT 53 tricyclic antidepressants TCAs 53 cardiovascular mortality 53 severe mitral regurgitation 53 coronary stenosis 53 HES CEL 53 neoadjuvant chemotherapy 53 ID TLR 53 induce orthostatic hypotension 53 FFR guided treatment 53 lipid lowering agents 53 antihypertensive therapy 53 Enhanced External Counterpulsation 53 HF hospitalization 53 NAVISTAR R 53 pancreatectomy 53 balloon valvuloplasty 53 thienopyridines 53 adverse cytogenetics 53 microbleeds 53 occlusion CRVO 53 aortic insufficiency 53 CIMZIA ™ 53 refractory AML 53 dobutamine 53 pulmonary hypertension PH 53 chronic periodontitis 53 pseudoaneurysm 53 anticoagulated 53 sunitinib malate 53 underwent resection 53 vinorelbine 53 anti arrhythmic drug 53 peripheral artery 53 Critical limb ischemia 53 prospective multicentre 53 STEMI undergoing 53 androgen deficiency 53 optic neuropathy 53 Uncontrolled hypertension 53 HORIZONS AMI trial 53 TAVI 53 artery occlusion 53 tracheal intubation 53 intravitreal injections 53 prodromal symptoms 53 certolizumab 53 radiotherapy SBRT 53 stented vessel 53 CIMZIA TM certolizumab pegol 53 TEVAR 53 periprocedural MI 53 coronary disease 53 SLNB 53 Acute coronary syndrome 53 octreotide LAR 53 AVODART 53 carotid angioplasty 53 ULORIC 53 surrogate endpoint 53 postintervention 53 LOVENOX 53 Decompensated Heart Failure 53 quetiapine 53 ABVD 53 Ischemic Stroke 53 gemcitabine Gemzar 53 neovascular 53 symptomatic pulmonary embolism 53 neutropenia dehydration dyspnea 53 paroxysmal 53 aortic root replacement 53 Non Alcoholic Steatohepatitis 53 coronary 53 coronary stent implantation 53 electrophysiologic 53 underwent angiography 53 nontraumatic 53 tipranavir r 53 catheter angiography 53 MEND CABG 53 bisoprolol 53 chronic GVHD 53 QTc prolongation 53 transthoracic 53 Radiofrequency ablation 53 open angle glaucoma 53 microvascular complications 53 unknown etiology 53 chronic myocardial ischemia 53 TMS Therapy 53 variant angina 53 biochemical relapse 53 curative resection 53 variceal 53 primary generalized tonic 53 vasovagal syncope 53 QTc 53 angiotensin receptor blocker ARB 53 ACE inhibitors 53 radiotherapy RT 53 estimated glomerular filtration 53 mucinous 53 Relapsing remitting MS 53 atrial arrhythmias 53 thrombocytosis 53 HBeAg positive patients 53 pretest probability 53 anticholinergics 53 proliferative retinopathy 53 metastatic neuroendocrine tumors 53 acute cholecystitis 53 Moyamoya disease 53 apnea hypopnea index 53 Intracranial 53 transurethral 53 vascular occlusion 53 OAB symptoms 53 gouty arthritis 53 clinically localized prostate 53 de novo lesions 53 Pulmonary embolism 53 annualized relapse 53 carotid artery stenosis 53 TACE 53 direct thrombin inhibitors 53 Bivalirudin 53 EDSS scores 53 typical antipsychotics 53 geographic atrophy 53 vein thrombosis 53 CYPHER ® 53 tiotropium 53 aortic dissection 53 malignant neoplasm 53 stent insertion 53 ischemic lesions 52 cirrhotic patients 52 Surgical resection 52 Warfarin Coumadin 52 intra abdominal abscess 52 pioglitazone HCl 52 endoluminal stent graft ELG 52 transapical 52 bivalirudin monotherapy 52 ivabradine 52 aromatase inhibitors AIs 52 osteoporotic compression fractures 52 Sleep disordered breathing 52 receiving prophylactic anticoagulation 52 nonresponders 52 fulminant 52 NYHA functional class 52 platelet inhibition 52 hemiparesis 52 lymphadenectomy 52 Catheterization 52 spinal cord compression 52 macroalbuminuria 52 TTF Therapy 52 adriamycin 52 Tasigna prolongs 52 lupus nephritis 52 Angiograms carry slight 52 psychiatric comorbidities 52 Left ventricular hypertrophy 52 PREZISTA r 52 generalized edema 52 cervical spine fractures 52 fulminant hepatitis 52 intravenous tissue plasminogen 52 vertebral compression fractures 52 stenting procedures